Lonidamine | 氯尼达明 | MedChemExpress (MCE)

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Lonidamine

CAS No. : 50264-69-2

MCE 国际站：Lonidamine

产品活性：Lonidamine (AF-1890) 是一种己糖激酶 (hexokinase) 和丙酮酸载体 (mitochondrial pyruvate carrier) 抑制剂 (K_i: 2.5 μM)。Lonidamine 还可抑制癌细胞中的有氧糖酵解。Lonidamine 可用于线粒体代谢和炎症的研究，如肺纤维化。

研究领域：Metabolic Enzyme/Protease  |  Apoptosis  |  Anti-infection

作用靶点：Hexokinase  |  Mitochondrial Metabolism  |  Apoptosis  |  Parasite

In Vitro: Lonidamine (100 μM, 24 h) inhibits TGF-β-stimulated lactate production and oxygen consumption rate in AKR-2B and TIG-1 cells.
Lonidamine (100 μM, 24/48 h) inhibits H2030BrM3 and A549 cell proliferation.
Lonidamine (100-200 μM, 24 h) inhibits H2030BrM3 and A549 cell invasion.
Lonidamine (100-1000 μM, 24 h) inhibits mitochondrial complex I and II activities.
Lonidamine (200 μM, 24 h) increases ROS generation in H2030BrM3 lung cancer cells.

In Vivo: Lonidamine (oral administration, 10-100 mg/kg/day, d10 to d20) improves lung function by inhibiting hexokinase 2 (HK2) activity in BLM-induced pulmonary fibrosis murine model.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Apoptosis Compound Library  |  Immunology/Inflammation Compound Library  |  Kinase Inhibitor Library  |  Metabolism/Protease Compound Library  |  Stem Cell Signaling Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Reprogramming Compound Library  |  Anti-COVID-19 Compound Library  |  Glycolysis Compound Library  |  Orally Active Compound Library  |  Glutamine Metabolism Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Lung Cancer Compound Library  |  Antiparasitic Compound library  |  Anti-Cancer Metabolism Compound Library  |  Anti-Parkinson's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Mitochondria-Targeted Compound Library  |  Glucose Metabolism Compound Library  |  Targeted Diversity Library  |  Human Metabolite Library  |  Anti-Prostate Cancer Compound Library  |  Anti-Pulmonary Fibrosis Compound Library  |  Cuproptosis Compound Library  |  Anti-Aging Natural Product Library  |  Cancer Stem Cells Compound Library  |  Heterocyclic Compound Library  |  Mitochondrial Protection Compound Library  |  Metabolic Enzyme Compound Library  |  Mitochondrial Toxicity Compound Library  |  Cell Death Library  |  Multi-Target Compound Library  |  MG-132  |  Chloroquine  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Tamoxifen  |  Y-27632  |  LY294002  |  Paclitaxel  |  Acetylcysteine  |  Angiotensin II human  |  2-Deoxy-D-glucose  |  Puromycin dihydrochloride  |  Staurosporine  |  Actinomycin D  |  SB-431542  |  5-Fluorouracil  |  Bortezomib  |  Deferoxamine mesylate  |  Oxaliplatin  |  Trametinib  |  Sorafenib  |  MitoSOX Red  |  Temozolomide  |  Gemcitabine  |  Decitabine  |  Mdivi-1  |  Elesclomol  |  Rotenone  |  Etoposide  |  Ruxolitinib

热门产品线：重组蛋白  |  药物筛选  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。